PET imaging of CCND1 mRNA in human MCF7 estrogen receptor–positive breast cancer xenografts with oncogene-specific [64Cu] chelator-peptide nucleic acid-IGF1 …
X Tian, MR Aruva, K Zhang, N Shanthly… - Journal of Nuclear …, 2007 - Soc Nuclear Med
Treatment of breast cancer is hampered by a large unmet need for rapid, sensitive, specific
staging and stratification of palpable and nonpalpable abnormalities. Mammography and …
staging and stratification of palpable and nonpalpable abnormalities. Mammography and …
External imaging of CCND1 cancer gene activity in experimental human breast cancer xenografts with 99mTc-peptide-peptide nucleic acid-peptide chimeras
X Tian, MR Aruva, W Qin, W Zhu, KT Duffy… - Journal of Nuclear …, 2004 - Soc Nuclear Med
Detection of a new or recurrent breast cancer lesion relies on physical examination and
imaging studies, primarily mammography, followed by histopathologic evaluation of biopsy …
imaging studies, primarily mammography, followed by histopathologic evaluation of biopsy …
External Imaging of CCND1, MYC, and KRAS Oncogene mRNAs with Tumor‐Targeted Radionuclide‐PNA‐Peptide Chimeras
X Tian, A Chakrabarti, NV Amirkhanov… - Annals of the New …, 2005 - Wiley Online Library
In 2005, breast cancer will kill approximately 40,410 women in the US, and pancreatic
cancer will kill approximately 31,800 men and women in the US Clinical examination and …
cancer will kill approximately 31,800 men and women in the US Clinical examination and …
Noninvasive 89Zr-transferrin PET shows improved tumor targeting compared with 18F-FDG PET in MYC-overexpressing human triple-negative breast cancer
KE Henry, TR Dilling, D Abdel-Atti… - Journal of Nuclear …, 2018 - Soc Nuclear Med
The current standard for breast PET imaging is 18F-FDG. The heterogeneity of 18F-FDG
uptake in breast cancer limits its utility, varying greatly among receptor status …
uptake in breast cancer limits its utility, varying greatly among receptor status …
A molecular approach to breast imaging
AM Fowler - Journal of Nuclear Medicine, 2014 - Soc Nuclear Med
Molecular imaging is a multimodality discipline for noninvasively visualizing biologic
processes at the subcellular level. Clinical applications of radionuclide-based molecular …
processes at the subcellular level. Clinical applications of radionuclide-based molecular …
Using nuclear medicine imaging in clinical practice: Update on PET to guide treatment of patients with metastatic breast cancer
AS Clark, E McDonald, MC Lynch, D Mankoff - Oncology, 2014 - go.gale.com
As we enter the era of personalized medicine, tests that can inform on molecular
mechanisms of cancer, and on breast cancer in particular, are in high demand. We currently …
mechanisms of cancer, and on breast cancer in particular, are in high demand. We currently …
[PDF][PDF] FDG-PET and beyond: molecular breast cancer imaging
A Quon, SS Gambhir - Journal of clinical oncology, 2005 - stati34521.narod.ru
Positron emission tomography (PET) scanning has gained widespread acceptance for the
diagnosis, staging, and management of a variety of malignancies, including breast cancer …
diagnosis, staging, and management of a variety of malignancies, including breast cancer …
c-Met PET imaging detects early-stage locoregional recurrence of basal-like breast cancer
A Arulappu, M Battle, M Eisenblaetter… - Journal of Nuclear …, 2016 - Soc Nuclear Med
Locoregional recurrence of breast cancer poses significant clinical problems because of
frequent inoperability once the chest wall is involved. Early detection of recurrence by …
frequent inoperability once the chest wall is involved. Early detection of recurrence by …
Novel PET biomarkers for breast cancer imaging
LM Kenny, A Al-Nahhas… - Nuclear medicine …, 2011 - journals.lww.com
Uncontrolled proliferation is one of the hallmarks of the malignant phenotype, and thus
represents a key target in the field of cancer therapeutics [1]. Quantitative measurement of a …
represents a key target in the field of cancer therapeutics [1]. Quantitative measurement of a …
Breast cancer models to study the expression of estrogen receptors with small animal PET imaging
A Aliaga, JA Rousseau, R Ouellette, J Cadorette… - Nuclear medicine and …, 2004 - Elsevier
Different animal models of estrogen positive tumors (ER+) were evaluated for their suitability
to follow tumor response after various treatment protocols, using small animal positron …
to follow tumor response after various treatment protocols, using small animal positron …
Related searches
- breast cancer pet imaging
- acid igf1 chelator peptide
- estrogen receptor chelator peptide
- estrogen receptor acid igf1
- pet imaging chelator peptide
- acid igf1 pet imaging
- breast cancer treatment of patients
- breast cancer 89zr transferrin
- estrogen receptor pet imaging
- breast cancer locoregional recurrence
- breast cancer clinical practice
- pet imaging locoregional recurrence
- acid peptide external imaging
- breast cancer molecular imaging
- pna peptide external imaging
- 99mtc peptide external imaging